Medical Applications of Single-Chain Antibodies

References

• Silverstein A. M. The history of immunology. Fundamental Immunology, Second Edition, W. E. Paul. Raven Press, New York 1989; 21–38
   Google Scholar
• Commemorative issue for the 100th anniversary of the discovery of antibodies (1890–1990). Molecular Immunology, R. S. Nezlin, 1991; 28: 1315–1412, 12
   Google Scholar
• Porter R. R. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem. J 1959; 73: 119–126
   PubMed Web of Science ®Google Scholar
• Edelman G. M. Dissociation of γ-globulin. J. Am. Chem. Soc 1959; 81: 3155–315
   Google Scholar
• Fieischman J. B., Porter R. R., Press E. M. The arrangement of the peptide chains in γ-globulin. Biochem. J 1963; 88: 220–228
   PubMedGoogle Scholar
• Immunoglobulin Genes, T. Honjo, F. W. Alt, T. H. Rabbits. Academic Press, New York 1989; 410
   Google Scholar
• Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 245: 495–497
   Google Scholar
• Waldmann T. A. Monoclonal antibodies in diagnosis and therapy. Science 1991; 252: 1657–1662
   PubMed Web of Science ®Google Scholar
• Winter G., Milstein C. Man-made antibodies. Nature 1991; 349: 293–299
   PubMed Web of Science ®Google Scholar
• Givol D. The minimal antigen-binding fragment of antibodies—Fv fragment. Molecular Immunology 1991; 28: 1379–1386
   PubMedGoogle Scholar
• Huston J. S., Levinson D., Mudgett-Hunter M., Tai M. -S., Novotny J., Margolies M. N., Ridge R. J., Bruccoleri R., Haber E., Crea R., Opperman H. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Nat. Acad. Sci., USA 1988; 85: 5879–5883
   PubMed Web of Science ®Google Scholar
• Huston J. S., Mudgett-Hunter M., Haber E., Oppermann H. Protein engineering of single-chain Fv immunoconjugates. SIM News 1988; 38((4) (Suppl.))11
   Google Scholar
• Huston J. S., Mudgett-Hunter M., Haber E., Oppermann H. Engineering immunoconjugates by gene fusion: Recovery of dual activity from a fusion protein comprising variable domains from antibody 26–10 and fragment B of protein A. Abstracts, 219. International Conference on Monoclonal Antibody Immunoconjugates in Cancer, San Diego, CA, 1989
   Google Scholar
• Huston J. S., Mudgett-Hunter M., Tai M. -S., Haber E., Oppermann H. Confirmation of binding site fidelity in biosynthetic single-chain Fv and a single-chain Fv immunoconjugate. The Biochemist 1989; 11((2) (Suppl))22
   Google Scholar
• McCartney J., Lederman L., Drier E., Wu G. -M., Cabral-Denison N., Huston J. S., Oppermann H. Biosynthetic antibody binding site (BABS) proteins: binding activities of MOPC 315 VH, Fv and single-chain Fv. ICSU Short Reports 1990; 10: 114
   Google Scholar
• Shealy D., Nedelman M., Tai M. -S., Huston J. S., Berger H., Lister-James J., Dean R. T. Characterization and biodistribution of Tc-99m labeled single chain antibody Fv fragment. J. Nuclear Med 1990; 31((5) (Suppl.))776–777
   Google Scholar
• Tai M. -S., Mudgett-Hunter M., Levinson D., Wu G. -M., Haber E., Oppermann H., Huston J. S. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry 1990; 29: 8024–8030
   PubMed Web of Science ®Google Scholar
• Huston J. S., Tai M. S., McCartney J., Warren F., Mudgett-Hunter M., Oppermann H. Bifunctional single-chain Fv fusion proteins. Bispecific Antibodies and Targeted Cellular Cytotoxicity: Proceedings of the Second International Conference, J.-L. Romet-Lemonne, M. W. Fanger, D. M. Segal. Fondation Nationale de Transfusion Sanguine, Les UlisFrance, 1991: 201–206
   Google Scholar
• McCartney J. E., Radcliffe R. D., Alvarez V. L., Rodwell J. D., Pang R. H. L., Warren F., Oppermann H. 1990, Unpublished results
   Google Scholar
• Nedelman M. A., Shealy D., Boutin R., Brunt E., Weisman H. F., McCartney J. E., Warren F. D., Oppermann H., Pang R. H. L., Berger H. J. Rapid infarct imaging with a new Tc-99m antimyosin sFv fragment: Evaluation in acute myocardial infarction in dogs. J. Nuclear Med 1991; 32(Suppl.)1005
   Google Scholar
• Huston J. S., Tai M. -S., Mudgett-Hunter M., McCartney J., Warren E., Haber E., Oppermann H. Protein engineering of single-chain Fv analogues and fusion proteins. Molecular Design and Modeling: Concepts and Applications, Part B, J. J. Langone. Methods in Enzymology, 1991; 203: 46–88
   Google Scholar
• McCartney J., Lederman L., Drier E., Cabral-Denison N., Wu G. -M., Batorsky R., Huston J. S., Oppermann H. Biosynthetic antibody binding sites: Development of a single-chain Fv model based on anti-dinitrophenol IgA myeloma MOPC 315. Journal of Protein Chemistry 1991; 10: 669–683
   PubMedGoogle Scholar
• McCartney J. E., Tai M. -S., Oppermann H., Jin D., Warren F. D., Weiner L. M., Bookman M. A., Stafford W. F., III, Houston L. L., Huston J. S. Refolding of single-chain Fv with C-terminal cysteine (sFv'): Formation of disulfide-bonded homodimers of anti-c-erbB-2 and anti-digoxin sFv'. Miami Short Reports 1993; 3: 91
   Google Scholar
• Nedelman M. A., Shealy D. J., Boutin R., Brunt E., Seasholtz J. I., Allen I. E., Weisman H. E., McCartney J. E., Warren F. D., Oppermann H., Pang R. H. L., Berger H. J. Rapid infarct imaging with a technetium-99m antimyosin sFv fragment: Evaluation in a canine model of acute myocardial infarction. J. Nuclear Med 1993; 34: 234–241
   PubMed Web of Science ®Google Scholar
• Huston J. S., Tai M. -S., McCartney J., Keck P., Oppermann H. Antigen recognition and targeted delivery by the single-chain Fv. In: Advances in the Applications of Monoclonal Antibodies in Clinical Oncology. Proceedings of the 9th Hammersmith Meeting, A. A. Epenetos. Chapman & Hall, London 1993, In press
   Google Scholar
• Huston J. S., Keck R., Tai M. -S., Jin D., McCartney J., Stafford W. E., III, Mudgett-Hunter M., Oppermann H., Haber E. Single-chain immunotechnology of Fv analogues and fusion proteins. Immunotechnology, J. Gosling, D. Reen. Portland Press, London 1993, In press
   Google Scholar
• Bird R. E., Hardman K. D., Jacobson J. W., Johnson S., Kaufman B. M., Lee S. -M., Lee T., Pope S. H., Riordan G. S., Whitlow M. Single-chain antigen-binding proteins. Science 1988; 242: 423–426
   PubMed Web of Science ®Google Scholar
• Bedzyk W. D., Weidner K. M., Denzin L. K., Johnson L. S., Hardman K. D., Pantoliano M. W., Ansel E. D., Voss E. W., Jr. Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody. J. Biol. Chem 1990; 265: 18615–18620
   PubMed Web of Science ®Google Scholar
• Colcher D., Bird R., Roselli M., Hardman K. D., Johnson S., Pope S., Dodd S. W., Pantoliano M. W., Milenic D. E., Schlom J. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Nat. Cancer Inst 1990; 82: 1191–1197
   PubMed Web of Science ®Google Scholar
• Gibbs R. A., Posner B. A., Filpula D. R., Dodd S. W., Finkelman M. A. J., Lee T. K., Wroble M., Whitlow M., Benkovic S. J. Construction and characterization of a single-chain catalytic antibody. Proc. Nat. Acad. Sci., USA 1991; 88: 4001–4004
   PubMed Web of Science ®Google Scholar
• Milenic D. E., Yokota T., Filpula D. R., Finkelman M. A. J., Dodd S. W., Wood J. E., Whitlow M., Snoy R., Schlom J. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Research 1991; 51: 6363–6371
   PubMed Web of Science ®Google Scholar
• Pantoliano M. W., Bird R. D., Johnson S., Asel E. D., Dodd S. W., Wood J. E., Hardman K. D. Conformational stability, folding and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli. Biochemistry 1991; 30: 10117–10125
   PubMedGoogle Scholar
• Yokota T., Milenic D. E., Whitlow M., Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992; 52: 3402–3408
   PubMed Web of Science ®Google Scholar
• Johnson S., Bird R. E. Construction of single-chain Fv derivatives of monoclonal antibodies and their production in Escherichia coli. Methods in Enzymology 1991; 203: 88–98
   PubMed Web of Science ®Google Scholar
• Whitlow M., Filpula D. Single-chain Fv proteins and their fusion proteins. Methods: A Companion to Methods in Enzymology 1991; 2: 97–105
   Google Scholar
• Batra J. K., Kasprzyk P. G., Bird R. E., Pastan I., King C. R. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proc. Nat. Acad. Sci., USA 1992; 89: 5867–5871
   PubMedGoogle Scholar
• Chaudhary V. K., Queen C., Junghans R. R., Waldmann T. A., FitzGerald D. J., Pastan I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 1989; 339: 394–397
   PubMed Web of Science ®Google Scholar
• Chaudhary V K., Batra J. K., Gallo M. G., Willingham M. C., FitzGerald D. J., Pastan I. A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins. Proc. Nat. Acad. Sci., USA 1990; 87: 1066–1070
   PubMed Web of Science ®Google Scholar
• Batra J. K., Chaudhary V. K., FitzGerald D., Pastan I. TGFα-anti-Tac(Fv)-PE40: A bifunctional toxin cytotoxic for cells with EGF or IL2 receptors. Biochem. Biophys. Res. Comm 1990; 171: 1–6
   PubMed Web of Science ®Google Scholar
• Batra J. K., FitzGerald D., Gately M., Chaudhary V. K., Pastan I. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. J. Biol. Chem 1990; 265: 15198–15202
   PubMed Web of Science ®Google Scholar
• Kreitman R. J., Chaudhary V. K., Waldmann T., Willingham M. C., FitzGerald D. I., Pastan I. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. Proc. Nat. Acad. Sci., USA 1990; 87: 8291–8295
   PubMed Web of Science ®Google Scholar
• Chaudhary V K., Gallo M. G., FitzGerald D. J., Pastan I. A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin. Proc. Nat. Acad. Sci., USA 1990; 87: 9491–9494
   PubMed Web of Science ®Google Scholar
• Batra J. K., FitzGerald D. J., Chaudhary V. K., Pastan I. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: Anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv). Mol. Cell. Biol 1991; 11: 2200–2205
   PubMed Web of Science ®Google Scholar
• Buchner J., Brinkmann U., Pastan I. Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology 1992; 10: 682–685
   PubMedGoogle Scholar
• Brinkmann U., Pai L. H., FitzGerald D. J., Willingham M., Pastan I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Nat. Acad. Sci., USA 1991; 88: 8616–8620
   PubMed Web of Science ®Google Scholar
• Seetharam S., Chaudhary V. K., FitzGerald D J., Pastan I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J. Biol. Chem 1991; 266: 17376–17381
   PubMed Web of Science ®Google Scholar
• Brinkmann U., Buchner J., Pastan I. Independent folding of Pseudomonas exotoxin and single-chain immunotoxins: Influence of interdomain connections. Proc. Nat. Acad. Sci., USA 1992; 89: 3075–3079
   PubMedGoogle Scholar
• Buchner J., Brinkmann U., Pastan I. Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology 1992; 10: 682–685
   PubMedGoogle Scholar
• Buchner J., Pastan I., Brinkmann U. A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem 1992; 205: 263–270
   PubMed Web of Science ®Google Scholar
• Glockshuber R., Malia M., Pfitzinger I., Plückthun A. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 1990; 29: 1362–1367
   PubMed Web of Science ®Google Scholar
• Skerra A., Pfitzinger I., Plückthun A. The functional expression of antibody Fv fragments in Escherichia coll. Improved vectors and a generally applicable purification technique. Bio/Technology 1991; 9: 273–278
   PubMed Web of Science ®Google Scholar
• Glockshuber R., Schmidt T., Plückthun A. The disulfide bonds in antibody variable domains: Effects on stability, folding in vitro, and functional expression in. Escherichia coli. Biochemistry 1992; 31: 1270–1279
   PubMed Web of Science ®Google Scholar
• Pack P., Plückthun A. Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked Fv fragments with high avidity in. Escherichia coli. Biochemistry 1992; 31: 1579–1534
   PubMed Web of Science ®Google Scholar
• McCafferty J., Griffiths A. D., Winter G., Chiswell D. J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552–554
   PubMed Web of Science ®Google Scholar
• Clackson T., Hoogenboom H. R., Griffiths A. D., Winter G. Making antibody fragments using phage display libraries. Nature 1991; 352: 624–628
   PubMed Web of Science ®Google Scholar
• Marks J. D., Hoogenboom H. R., Bonnert T. P., McCafferty J., Griffiths A. D., Winter G. Bypassing immunization: Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol 1991; 222: 581–597
   PubMed Web of Science ®Google Scholar
• Marks J. D., Griffiths A. D., Malmqvist M., Clackson T. R., Bye J. B., Winter G. By-passing immunization: Building high affinity human antibodies by chain shuffling. Bio/Technology 1992; 10: 779–783
   PubMed Web of Science ®Google Scholar
• Marks J. D., Hoogenboom H. R., Griffiths A. D., Winter G. Molecular evolution of proteins on filamentous phage. J. Biol. Chem 1992; 267: 16007–16010
   PubMed Web of Science ®Google Scholar
• Iverson B. L., Iverson S. A., Roberts V. A., Getzoff E. D., Tainer J. A., Benkovic S. J., Lerner R. A. Metalloantibodies. Science 1990; 249: 659–662
   PubMedGoogle Scholar
• Roberts V A., Iverson B. L., Iverson S. A., Benkovic S. J., Lerner R. A., Getzoff E. D., Tainer J. A. Antibody remodeling: A general solution to the design of a metal-coordination site in an antibody binding pocket. Proc. Nat. Acad. Sci., USA, 87: 6654–6658
   PubMedGoogle Scholar
• Condra J. H., Sardana V. V., Tomassini J. E., Schlabach A. J., Davies M. -E., Lineberger D. W., Gotlib L., Colonno R. J. Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells. J. Biol. Chem 1990; 265: 2292–2295
   PubMed Web of Science ®Google Scholar
• Davis G. T., Bedzyk W D., Voss E. W., Jacobs T. W. Single-chain antibody (SCA) encoding genes: One-step construction and expression in eukaryotic cells. Bio/Technology 1991; 9: 165–169
   PubMedGoogle Scholar
• Laroche Y., Demaeyer M., Stassen J. -M., Gansemans Y., Demarsin E., Matthyssens G., Collen D., Holvoet R. Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer. J. Biol. Chem 1991; 266: 16343–16349
   Google Scholar
• Holvoet P., Laroche Y., Lijnen H. R., Van Cauwnberge R., Demarsin E., Brouwers E., Matthyssens G., Collen D. Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase. J. Biol. Chem 1991; 266: 19717–19724
   PubMedGoogle Scholar
• Anand N. N., Mandal S., MacKenzie C. R., Sadowska J., Sigurskjold B., Young N. M., Bundle D. R., Narang S. A. Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen. J. Biol. Chem 1991; 266: 21874–21879
   PubMed Web of Science ®Google Scholar
• Fuchs R., Breitling E., Dübel S., Seehaus T., Little M. Targeting recombinant antibodies to the surface of Escherichia coli: Fusion to a peptidoglycan associated lipoprotein. Bio/Technology 1991; 9: 1369–1372
   PubMedGoogle Scholar
• Breitling E., Dübel S., Seehaus T., Klewinghaus I., Little M. A surface expression vector for antibody screening. Gene 1991; 104: 147–153
   PubMed Web of Science ®Google Scholar
• Dübel S., Breitling E., Seehaus T., Little M. Generation of a human IgM expression library in E. coli. Methods in Molecular and Cellular Biology 1992; 3: 47–52
   Google Scholar
• Seehaus T., Breitling E., Dübel S., Klewinghaus I., Little M. A vector for the removal of deletion mutants from antibody libraries. Gene 1992; 114: 235–237
   PubMed Web of Science ®Google Scholar
• Takkinen K., Laukkanen M. -L., Sizmann D., Alfthan K., Immonen T., Vanne L., Kaartinen M., Knowles J. K. C., Teeri T. T. An active single-chain antibody containing a cellulase linker domain is secreted by. Escherichia coli. Prot. Eng 1991; 4: 837–841
   PubMedGoogle Scholar
• Dreher M. L., Gherardi E., Skerra A., Milstein C. Colony assays for antibody fragments expressed in bacteria. J. Immunol. Methods 1991; 139: 197–205
   PubMed Web of Science ®Google Scholar
• Kohl J., Riiker F., Himmler G., Razazzi E., Katinger H. Cloning and expression of an HIV-1 specific single-chain Fv region fused to Escherichia coli alkaline phosphatase. Ann. N. Y. Acad. Sci., USA 1991; 646: 106–114
   PubMedGoogle Scholar
• Weidner K. M., Voss E., Jr. Immunological characterization of Xenogenic anti-metatype antibodies. J. Biol. Chem 1991; 266: 2513–2519
   PubMed Web of Science ®Google Scholar
• Cheadle C., Hook L. E., Givol D., Ricca G. A. Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: Recovery of active Fv fragments. Molecular Immunology 1992; 29: 21–30
   PubMed Web of Science ®Google Scholar
• Bregegere F., Bedouelle H. Expression, export and purification of antibody fragments fused to the maltose binding protein of Escherichia coli. Comptes Rendus de l'Academie des Sciences. Series III - Sciences de la Vie 1992; 314: 527–532
   PubMedGoogle Scholar
• Wels W., Harwerth I. -M., Zwickl M., Hardman N., Groner B., Hynes N. E. Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Bio/Technology 1992; 10: 1128–1132
   PubMedGoogle Scholar
• Wels W., Harwerth I. M., Hynes N. E., Groner B. Diminution of antibodies directed against tumor cell surface epitopes: A single chain Fv fusion molecules specifically recognizes the extracellular domain of the c-erbB-2 receptor. J. Steroid Biochem. Molec. Biol 1992; 43: 1–7
   PubMedGoogle Scholar
• Wels W., Harwerth I. -M., Mueller M., Groner B., Hynes N. E. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res 1992; 52: 6310–6317
   PubMed Web of Science ®Google Scholar
• Mottez E., Jaulin C., Godeau F., Choppin J., Levy J. -P., Kourilsky P. A single-chain murine class I major transplantation antigen. Eur. J. Immunol 1991; 21: 467–471
   PubMedGoogle Scholar
• Traunecker A., Lanzavecchia A., Karjalainen K. Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J 1991; 10: 3655–3659
   PubMed Web of Science ®Google Scholar
• Novotny J., Ganju R. K., Smiley S. T., Hussey R. E., Luther M. A., Recny M. A., Siliciano R. F., Reinherz E. A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. Proc. Nat. Acad. Sci., USA 1991; 88: 8646–8650
   PubMedGoogle Scholar
• Hoo W. F. S., Lacy M. J., Denzin L. K., Voss E. W., Jr., Hardman K. D., Kranz D. M. Characterization of a single-chain T-cell receptor expressed in Escherichia coli. Proc. Nat. Acad. Sci. USA 1992; 89: 4759–4763
   PubMedGoogle Scholar
• Ward E. S. Secretion of T cell receptor fragments from recombinant Escherichia coli cells. J. Mol. Biol 1992; 224: 885–890
   PubMedGoogle Scholar
• Duchosal M. A., Eming S. A., Fischer P., Leturcq D., Barbas C. F., III, McConahey P. J., Caothien R. H., Thornton G. B., Dixon F. J., Burton D. R. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 1992; 355: 258–262
   PubMed Web of Science ®Google Scholar
• Smith T. W., Butler V P., Jr., Haber E., Fozzard H., Marcus F. I., Bremner W. E., Schulman I. C., Phillips A. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: Experience in 26 cases. N. Engl. J. Med 1982; 307: 1357–1362
   PubMed Web of Science ®Google Scholar
• Lechat R., Mudgett-Hunter M., Margolies M. N., Haber E., Smith T. W. Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments. J. Pharm. Expt. Therapeut 1984; 229: 210–213
   PubMed Web of Science ®Google Scholar
• Huston J. S., Bjork I., Tanford C. Properties of the Fd fragment from rabbit immunoglobulin G. Biochemistry 1972; 11: 4256–4262
   Google Scholar
• Roberts S., Cheetham J., Rees A. R. Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering. Nature 1989; 328: 731–734
   Google Scholar
• Dias J. A., Huston J. S., Reichert L. E., Jr. Differential effects of monovalent and bivalent antisera on the interaction of follicle stimulating hormone with its receptor. Endocrinol 1984; 114: 1259–1265
   PubMedGoogle Scholar
• Painter R. G., Sage H. J., Tanford C. Contributions of heavy and light chains of rabbit immunoglobulin G to antibody activity. I. Binding studies on isolated heavy and light chains. Biochemistry 1972; 11: 1327–1337
   Google Scholar
• Fischmann T. O., Bentley G. A., Bhat T. N., Boulot G., Mariuzza R. A., Phillips S. E. V., Tello D., Poljak R. J. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5 Å resolution. J. Biol. Chem 1991; 266: 12915–12920
   PubMed Web of Science ®Google Scholar
• Bernstein F. C., Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The protein data bank: a computer-based archival file for macromolecular structures. J. Mol. Biol 1977; 112: 535–542
   PubMed Web of Science ®Google Scholar
• Mudgett-Hunter M., Margolies M. N., Ju A., Haber E. High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. J. Immunol 1982; 129: 1165–1172
   PubMedGoogle Scholar
• Khaw B. -A., Mattis J. A., Melincoff G., Strauss H. W., Gold H. K., Haber E. Monoclonal antibody to cardiac myosin: Imaging of experimental myocardial infarction. Hybridoma 1984; 3: 11–23
   PubMed Web of Science ®Google Scholar
• Zalutsky M. R., Garg P. K., Johnson S. H., Utsunomiya H., Coleman R. E. Fluorine-18-antimyosin monoclonal antibody fragments: Preliminary investigations in a canine myocardial infarct model. J. Nucl. Med 1992; 33: 575–580
   PubMedGoogle Scholar
• Cumber A. J., Ward E. S., Winter G., Parnell G. D., Wawrzynczak E. J. Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J. Immunol 1992; 149: 120–126
   PubMed Web of Science ®Google Scholar
• King D. J., Mountain A., Adair J. R., Owens R. J., Harvey A., Weir N., Proudfoot K. A., Phipps A., Lawson A., Rhind S. K., Pedley B., Boden J., Boden R., Begent R. H. J., Yarranton G. T. Tumor localization of engineered antibody fragments. Antibody Immunoconj. Radiopharmaceut 1992; 5: 159–170
   Google Scholar
• Huston J. S., Cohen C., Maratea D., Fields E., Tai M. -S., Cabral-Denison N., Juffras R., Rueger D. C., Ridge R. J., Oppermann H., Keck R., Baird L. G. Multisite association by recombinant proteins can enhance binding selectivity: Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A. Biophysical Journal 1992; 62: 87–91
   PubMedGoogle Scholar
• Anthony J., Near R., Wong S. -L., Iida E., Ernst E., Wittekind M., Haber E., Ng S. -C. Production of stable anti-digoxin Fv in Escherichia coli. Mol. Immunol 1992; 29: 1237–1247
   PubMed Web of Science ®Google Scholar
• Gherardi E., Milstein C. Original and artificial antibodies. Nature 1992; 357: 201–202
   PubMedGoogle Scholar
• Schott M. E., Milenic D. E., Yokota T., Whitlow M., Wood J. F., Fordyce W. A., Cheng R. C., Schlom I. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res 1992; 52: 6413–6417
   PubMedGoogle Scholar
• Ayala M., Duenas M., Santos A., Vazquez J., Menendez A., Silva A., Gavilondo J. V. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen. BioTechniques 1992; 13: 790–799
   PubMed Web of Science ®Google Scholar
• Owen M., Gandecha A., Cockburn B., Whitelam G. Synthesis of a functional anti-phytochrome single-chain Fv protein in transgenic tobacco. Bio/Technology 1992; 10: 790–794
   PubMed Web of Science ®Google Scholar
• Gandecha A. R., Owen M. R. L., Cockburn B., Whitelam G. C. Production and secretion of a bifunctional staphylococcal protein A::antiphytochrome single-chain Fv fusion protein in Escherichia coli. Gene 1992; 122: 361–365
   PubMedGoogle Scholar
• Malby R. L., Lawrence M., Tulip W. R., Harley V. R., Webster R. G., Hudson P. J., Colman P. M. Crystal structure of the complex between a single-chain antibody and neuraminidase: A basis for rational protein engineering. Miami Short Reports 1993; 3: 85
   Google Scholar
• Hoogenboom H. R., Winter G. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol 1992; 227: 381–388
   PubMed Web of Science ®Google Scholar
• Wu X -C., Ng S. -C., Near R. J., Wong S. -L. Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system. Bio/Technology 1993; 11: 71–76
   PubMedGoogle Scholar
• Knappik A., Krebber C., Plückthun A. The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in. Escherichia coli. Bio/Technology 1993; 11: 77–83
   Google Scholar
• Friedman P. N., McAndrew S. J., Gawlak S. L., Chace D., Trail P. A., Brown J. R., Siegall C. G. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells. Cancer Research 1993; 53: 334–339
   PubMed Web of Science ®Google Scholar
• Brigido M. M., Polymenis M., Stollar B. D. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules. J. Immunol 1993; 150: 469–479
   PubMedGoogle Scholar
• Kurucz I., Jost C. R., George A. J.T., Andrew S. M., Segal D. M. A bacterially-expressed single chain Fv construct from the 2B4 T cell receptor. Proc. Nat. Acad. Sci., USA 1993; 90, In press
   Google Scholar
• Mage M. G., Lee L., Ribaudo R. K., Corr M., Kozlowski S., McHugh L., Margulies D. H. A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity. Proc. Nat. Acad. Sci., USA 1992; 89: 10658–10662
   PubMedGoogle Scholar
• Embleton M. J., Gorochov G., Jones P. T., Winter G. In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells. Nucleic Acids Res 1992; 20: 3831–3837
   PubMed Web of Science ®Google Scholar